Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 10/20 10:00:00 pm
154.63USD
+0.02%
Upcoming events
10/25/17 | 22:30
Q3 2017 Earnings Call
10/25/17
Q3 2017 Earnings Release
11/03/17 | 15:35
North American Cystic Fibrosis Conference
01/31/18
FY 2017 Earnings Release (Projected)
Past Events
09/27/17 | 05:30pmLEERINK Partners Rare Disease & Immuno-Oncology Conference
09/11/17 | 07:40pmMorgan Stanley Global Healthcare Conference
08/08/17MUFG Securities Seattle Investor Conference
07/26/17 | 10:01pmInterim 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
1 701
1 696
0,30%

2 297
Operating income (EBITDA)
Million $
Released
Forecast
Spread
350
329
6,2%

482
Operating profit (EBIT)
Million $
Released
Forecast
Spread
288
242
19%

487
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-112
-133
16%

203
EPS
 $
Released
Forecast
Spread
-0,46
-0,46
-0,94%

0,72
Announcement Date01/25/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
544
487
12%

519
Operating income (EBITDA)
Million $
Released
Forecast
Spread



63,5
Operating profit (EBIT)
Million $
Released
Forecast
Spread
112
88,8
27%

88,8
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
18,0
13,4
34%

-104
EPS
 $
Released
Forecast
Spread
0,07
0,07
-4,2%

-0,44
Announcement Date07/26/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise